National Urban Learning Platform launched as urban arm of iGOT-Mission Karmayogi (See 'Corp Brief') CSIR-NIScPR Organized Skill Training Programme on Basics of Koha Software (See 'Corp Brief') PMLA- Forfeiture unsustainable where nexus between property and illegally acquired income not established: SAFEMA (See 'Legal Desk') The Income Tax Act, 2025: Privacy, Power, and Constitutional Scrutiny (See CORP EINSICHT ) India has made Remarkable Progress Against Leprosy: Govt (See 'Corp Brief') Agra, Chennai, Kanpur among Key Footwear Clusters to benefit from QCI-FDDI Partnership (See 'Corp Brief') Bharat Innovates reinforces vision of NEP 2020: Pradhan (See 'Corp Brief') Indo–French Partnership to advance Global Deep Tech, Innovation, and Start-up Ecosystems (See 'Corp Brief') Discussions between MoS and DG, ILO underline rapid expansion in India's social security coverage (See 'Corp Brief') Ministry of Coal holds Successful Roadshow on Coal and Lignite Gasification Projects (See 'Corp Brief') Textile Sector witnesses unprecedented growth and transformation: Giriraj Singh (See 'Corp Brief') 'Oilseeds Kisaan Mitra' - India's First Nationwide WhatsApp AI Advisory for Oilseed Farmers (See 'Corp Brief') IBC - If application for withdrawal of CIRP u/s 12A is supported by duly submitted Form FA, accompanied by required bank guarantee, and placed before CoC within prescribed time, AA may permit withdrawal of CIRP: NCLT (See 'Legal Desk') IPC strengthens Industry Preparedness for IP 2026 (See 'Corp Brief') Vaishnaw inaugurates 20 kW Akashvani FM Transmitter at Ramgarh, Jaisalmer (See 'Corp Brief') Goyal to visit Switzerland to promote India-EFTA trade deal (See 'Corp Brief') MoS calls upon Industry to scale up Investments in India's Space Sector (See 'Corp Brief') IBC - Incorrect disclosure in Form B does not by itself extinguish statutory charge, particularly where RP otherwise had notice of lien and statutory basis claimed by tax authority: NCLAT (See 'Legal Desk') SAPLING Dialogue 2026 Concludes with Call for holistic development of food processing Sector (See 'Corp Brief') Measures activated to shield Domestic Fertilizer Supply from Global Geo-Political Disruptions: Govt (See 'Corp Brief') CCI approves acquisition of certain shareholding in PUMA SE by Ancat Holding (See 'Corp Brief') IBC - Write-off of inventory may be held fraudulent u/s 66(1) if surrounding facts show non-maintenance and withholding of stock records, inconsistency between inventory figures and operational trends: NCLT (See 'Legal Desk') CCI approves acquisition of equity in Shriram Life Insurance by Sanlam Emerging Markets (See 'Corp Brief') Ministry of Coal to organize Roadshow on Coal and Lignite Gasification Projects in Hyderabad (See 'Corp Brief') MoS leads delegation at 114th International Labour Conference in Geneva (See 'Corp Brief') No ban on Import of Indian Mangoes by Nepal (See 'Corp Brief') IBC - Advance paid to corporate debtor for supply of goods or services, where claim has nexus with provision of goods or services, constitutes operational debt within meaning of Sec 5(21): NCLT (See 'Legal Desk') TRAI issues amended 'Rating Manual 2026' for assessment of Digital Connectivity (See 'Corp Brief') Zojila Tunnel to establish All-Weather Connectivity Between J&K and Ladakh (See 'Corp Brief') IPR - Foreign FRAND rate-setting action filed by implementer may be treated as relevant material at pro tem stage in assessing prima facie essentiality / need for licensing: HC (See 'Legal Desk') Ministry of MSME Promoting Inclusive Entrepreneurship through National SC-ST Hub Scheme (See 'Corp Brief') GeM Boosts MSE Inclusion: Registered Units Rise to 11.9 Lakh (See 'Corp Brief') Strong, transparent and modern cooperative institutions will energise rural economy: Bhutani (See 'Corp Brief') Trade Marks - CALPOL & CALPOL FAST medicines granted status of well-known trademark as material demonstrates strong consumer association of mark with Plaintiff & its distinctiveness in pharma sector: HC (See 'Legal Desk') SAIL sharpens strategic priorities for FY27, reinforces market position (See 'Corp Brief') Railways sanctions upgradation of Electric Traction System on Bengaluru-Tumkur Section (See 'Corp Brief') IBC - Once resolution plan was approved by CoC, successful resolution applicant is bound by it and cannot seek to evade implementation by raising objections to LoI stipulations that are inherent in process: SC (See 'Legal Desk') Railways sanctions upgradation of Electric Traction System on Mahbubnagar-Secunderabad Section (See 'Corp Brief') Capital Market - Finding of 'fraud' under SEBI PFUTP Regulations, 2003, cannot be sustained, if Securities Appellate Tribunal had committed 'egregious error' in affirming SEBI's conclusions on manipulation & fraudulent intent: SC (See 'Legal Desk') MoS inaugurates Self-ticketing Kiosks at National Zoological Park (See 'Corp Brief') Ministry of Panchayati Raj to organise outreach workshop on Atmanirbhar Panchayat Program (See 'Corp Brief') Mandaviya leads nationwide World Bicycle Day celebrations with actor Vikrant Massey (See 'Corp Brief') IPR - Nature of enquiry u/s 57, being one for cancellation or rectification of register, is founded upon appreciation of statutory parameters such as distinctiveness, prior use and likelihood of confusion: HC (See 'Legal Desk') MoS inaugurates Daycare Facility for Children of MSDE Employees at Kaushal Bhawan (See 'Corp Brief') National Biodiversity Authority Celebrates World Environment Day 2026 (See 'Corp Brief') AI-enabled Sayuj App & Open Challenge Program 1.0 launched to strengthen Startup Ecosystem: MoS (See 'Corp Brief') Over 6,000 youth from across country to celebrate innovation & leadership (See 'Corp Brief') IBC - Land leased by statutory authority cannot be excluded from Corporate Debtor's assets on ground that development rights were transferred without consent: NCLT (See 'Legal Desk') IBC's Primacy Over the Electricity Act and the Extinguishment of Pre-CIRP Claims (See CORP EINSICHT)

Print

Govt hosts workshop on increasing R&D in pharma-medical tech sector

Published: Mar 13, 2025

By TIOLCorplaws News Service

NEW DELHI, MAR 13, 2025: THE Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, organised a workshop on the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) Scheme today. The workshop was inaugurated in the presence of the Secretaries of five stakeholder Ministries and Departments of the Government of India, namely, Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General (DG), Council of Scientific and Industrial Research (CSIR); and Dr Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, Indian Council for Medical Research (ICMR). The workshop served as a platform for identifying key action points and approaches to further the shared commitment to promote research and development in the pharmaceuticals and medical technologies sector.

Amit Agrawal, Secretary, Department of Pharmaceuticals highlighted the rapid expansion in the sector, underscoring the importance of research and innovation in driving making and innovating in India for India and the world. In this regard, he highlighted that the global share of personalised and precision technology platforms (such as antibody-drug conjugates, bi-specific antibodies, and cell and gene therapy) among the top-100 drugs by value is growing rapidly, from 5% in 2020 to 9% in 2025 and projected to grow to 20% by 2030. He also highlighted the 10 times increase in the number of Indian healthcare and life sciences startups over the last four years, from over 900 in 2020 to more than 10,000 in 2024, as well as the growing pipeline of innovative products of Indian firms.

Amit Agrawal said that the groundwork and the pipeline for projects for the PRIP scheme has been laid through this growing innovation ecosystem of Indian startups and industry, supported by a wide array of initiatives of the scientific Ministries/ Departments. The latter include the clinical trial network created by CSIR under its INTENT initiative; the patenting support available through DST's TIFAC and ICMR's Patent Mitra initiative; the handholding support available to both medical technology and drug innovations through ICMR's MedTech Mitra initiative; the funding support available to startups through Department of Biotechnology's BIRAC, MeitY's TIDE 2.0 and SAMRIDH schemes and DST's Quantum Computing Mission, etc.

Reiterating the Government's commitment to a robust research ecosystem, Amit said that PRIP is a transformative initiative aimed at catalysing innovation, strengthening industry-academia linkages, and positioning India as a global leader in pharmaceutical and MedTech research.

Prof. Abhay Karandikar, Secretary, DST underscored the importance of cutting-edge scientific research in driving advancements in pharmaceuticals and MedTech, reinforcing India's healthcare ecosystem and highlighted the supports available through the extensive incubator and accelerator network of DST.

S. Krishnan, Secretary, MeitY emphasised the transformative potential of digital health, artificial intelligence (AI) and data-driven technologies in drug discovery and medical device development. He highlighted the research strengths of MeitY's organisations, such as Society for Applied Microwave Electronics Engineering and Research (SAMEER), C-DAC and Centre for Materials for Electronics Technology (C-MET).

Dr Rajiv Bahl, Secretary, DHR and DG, ICMR highlighted the critical role of clinical research, indigenous drug development and regulatory advancements in accelerating pharmaceutical innovation. He offered the full support of the ICMR INTENT, MedTech Mitra and Patent Mitra initiatives in taking forward the shared goals of PRIP scheme. He also said that the industry-academia collaborative research window under the scheme could be of considerable help in taking forward the large volume of intramural and extramural research being funded by ICMR to the market with funding from PRIP and industry involvement.

Dr N. Kalaiselvi, Secretary, DSIR and DG, CSIR underscored the need to foster a culture of scientific collaboration between research institutions and industry to ensure the seamless translation of research into commercially viable applications. She highlighted that considerable research done in CSIR labs could be taken to the market through collaboration with industry and funding from PRIP.

The discussions reaffirmed the Government's vision of transforming India into a global hub for research and innovation in pharmaceuticals and medical technology. The workshop featured four dedicated breakout sessions, bringing together over 100 participants from leading scientific departments and premier institutions, including the National Institutes of Pharmaceutical Education and Research, IITs, CSIR labs and organisations of ICMR, MeitY, DST and Department of Bio technology, along with key government enablers for the ecosystem. Key deliberations covered the emerging trends in pharmaceutical and MedTech research, strategies for translating research into commercially viable products, government support mechanisms to accelerate sectoral growth and flexibilities sought to maximise the impact from the PRIP scheme.

All participants were requested to share their suggestions in the Expression of Interest (EoI) form for the PRIP scheme hosted on the website of the Department of Pharmaceuticals, so that these may be taken into account while taking forward the scheme and enabling participants. The EoI would be open till April 7, 2025.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.